Lenskart IPO Opens: Price Band ₹402–₹500, GMP Soars 24%, and ₹7,278 Cr Mega Issue Sparks Investor Frenzy | October 2025

Lenskart IPO Opens: Price Band ₹402–₹500, GMP Soars 24%, and ₹7,278 Cr Mega Issue Sparks Investor Frenzy | October 2025

Roshan Singh — Co-Founder, GAINIPO
October 28, 2025

Lenskart IPO Opens — ₹7,278 Cr Eyewear Giant Set to Redefine India’s D2C Listings

The long-awaited Lenskart Solutions IPO has officially opened for subscription, and investor enthusiasm is sky-high.
Backed by marquee global investors and a robust omni-channel model, Lenskart is among India’s most profitable and recognizable consumer brands to enter the stock market in 2025.


#1 — IPO Snapshot: Key Dates and Price Details

Category: IPO / Markets

Key Highlights

  • IPO Open: 30 October 2025
  • IPO Close: 03 November 2025
  • Basis of Allotment: 05 November 2025
  • Listing Date: 09 November 2025
  • Price Band: ₹402 – ₹500 per share
  • Lot Size: 37 shares
  • Issue Size: ₹7,278 Crore (Fresh + OFS)
  • Grey Market Premium (GMP): ₹98 → ~24.38 % over upper band *(as of 28 Oct 2025) view latest gmp *

Detailed Report

According to filings with SEBI and the exchanges, Lenskart Solutions Ltd aims to raise ₹7,278 crore through a combination of fresh issue and Offer for Sale.
Retail investors can apply for a minimum lot of 37 shares, translating to an investment of roughly ₹14,874.

Lead managers include Kotak Mahindra Capital, Goldman Sachs, and Morgan Stanley, indicating strong institutional participation.
Market trackers report a GMP of ₹98, implying about 24 % listing gain potential if sentiment holds steady.


#2 — Company Overview: From Startup to Eyewear Empire

Category: Business / D2C

Key Highlights

  • Founded by Peyush Bansal (of Shark Tank India fame) in 2010.
  • Operates across 1,800+ stores in 400+ cities with a strong digital platform.
  • Global presence in Singapore, UAE, USA, and the Middle East.
  • Offers spectacles, contact lenses, sunglasses, and vision-tech solutions.

Detailed Report

Lenskart revolutionized India’s optical-retail industry by combining technology, affordability, and style.
The brand now serves over 25 million customers, powered by AI-based eye testing and 3D frame try-on tools.

Financially, Lenskart became profitable in FY 2025, posting revenue above ₹3,500 Cr and net profit around ₹260 Cr, driven by strong domestic and international expansion.
Its vertically integrated Bhiwadi factory → home delivery supply chain provides a long-term cost edge over competitors.


#3 — Financial Performance Snapshot (FY 2025)

MetricFY 2025FY 2024Growth
Revenue₹3,516 Cr₹2,805 Cr+25 %
EBITDA₹690 Cr₹518 Cr+33 %
Net Profit₹262 Cr₹130 Cr+101 %
EBITDA Margin19.6 %18.5 %
ROE21 %13 %

Lenskart’s solid profit growth makes it stand apart from most consumer-tech IPOs, which often go public while still loss-making.


#4 — IPO Valuation & Analyst View

Category: Market Analysis

Key Highlights

  • Post-issue valuation estimated at ₹45,000 – ₹50,000 Cr.
  • P/E ratio around 80–90× FY25 EPS — high but supported by brand visibility.
  • Analysts cite strong brand recall, export potential, and supply-chain control as key value drivers.

Detailed Report

Brokerages believe valuations are premium but sustainable, given Lenskart’s profitability and scale.
India’s eyewear market is forecast to grow at a ~10 % CAGR till 2030, while Lenskart’s international presence adds upside potential.

However, analysts warn that rich pricing and competition from Titan Eye+ and other D2C brands could cap short-term returns.

Expert View: “Lenskart is a rare profitable D2C brand with global ambition. Valuation is full — but quality never comes cheap.” — Motilal Oswal Securities


#5 — GMP Trend & Listing Expectations

Category: Market Sentiment

Key Highlights

  • GMP steady: ₹95–₹100 (~20–25 % potential listing gain).
  • Anchor Investors: Temasek, ADIA, Premji Invest — strong institutional interest.
  • Retail Subscription: Expected to exceed 25×, driven by brand trust.

Detailed Report

GainIPO’s GMP Tracker shows consistent grey-market activity ahead of listing.
Participation from global funds like Temasek and ADIA confirms institutional confidence.
Analysts expect Lenskart to list around ₹600–₹625 if markets remain stable.

Expert View: “The IPO ticks all boxes — strong financials, visible growth, and brand power. If markets stay stable, it could be one of 2025’s top listings.” — Market analysts to Moneycontrol


#6 — Risk Factors to Watch

  • High valuation multiples vs peers (Titan Eye+, Vision Express).
  • Imported raw materials dependency → margin risk if INR weakens.
  • Heavy offline expansion costs may reduce near-term profit.
  • Promoter dilution could lead to post-listing supply pressure.

Summary Takeaway

The Lenskart IPO combines brand power, profitability, and global reach — a rare mix in India’s D2C space.
With a ₹7,278 Cr issue, strong GMP, and top-tier anchor book, it’s a promising listing, though valuations are stretched.

GAINIPO Verdict: Long-Term Positive 💼 | Short-Term Premium Listing Likely 🚀


Explore More on GAINIPO


Lenskart IPO GMP
Lenskart IPO review
Lenskart IPO price band
Lenskart IPO listing date
Lenskart IPO allotment date
Upcoming IPOs 2025 India
Best IPOs to apply.

Share this post

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.

Disclaimer: All information on GAINIPO is for educational purposes only and is not investment advice. Please consult a SEBI-registered financial advisor before making any decisions. We are not liable for any financial losses.